EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension

Hui Liu, Siyun Liu, Pengsheng Ma, Long Ma, Yuxin Liu, Fang Zhao, Ru Zhou

International Journal of Nanomedicine · 2025

DOI: 10.2147/ijn.s489133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025. Verfasst von Hui Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Ningxia Medical University, Yinchuan, 750004, People's Republic of China. Hauptthemen laut MEDLINE: Drug Carriers, Lipids, Nanostructures, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study focuses on the development and evaluation of nanostructured lipid carriers (NLCs) loaded with aloperine as a potential therapeutic approach for the treatment of pulmonary arterial hypertension.

Methods

The NLCs were designed to enhance the solubility, stability, and bioavailability of aloperine, a compound with vasodilatory and anti-inflammatory properties. Through a series of experiments including single-factor experimentation, transmission electron microscopy, high-performance liquid chromatography, in vivo pharmacokinetics, and tissue distribution studies, we assessed the physicochemical properties, drug release profiles, and in vitro and in vivo performance of this novel nanocarrier.

Results

The prepared aloperine-loaded NLCs exhibited a milky white and translucent suspension appearance, presenting a quasi-spherical shape under a transmission electron microscope, with an average particle size of (509.48± 30.04) nm and an entrapment efficiency of (64.18± 1.14)%. The drug release profile demonstrated good sustained-release characteristics in vitro, and the formulation remained stable for up to 15 days when stored at 4°C. Compared to the aloperine solution group, the t 1/2 , AUC (0→t) , AUC (0→∞) , MRT (0→t) , and clearance rate of the aloperine-loaded NLCs were 2.3, 2.96, 3.06, 3.03, and 0.22 times higher, respectively. This indicates that formulating aloperine into NLCs can prolong its circulation time in the body. Furthermore, the concentrations of aloperine in the lungs of the NLCs group were 1.79, 3.78, and 2.30 times higher than those in the solution group at three time points (0.25 h, 1.5 h, 4 h), suggesting that NLCs can increase the accumulation of aloperine in the lungs.

Conclusion

Our findings suggest that NLCs loaded with aloperine could offer a promising strategy for the treatment of pulmonary arterial hypertension. Keywords: aloperine, nanostructured lipid carrier, aerosol inhalation, pharmacokinetics

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug CarriersLipidsNanostructuresPulmonary Arterial HypertensionPiperidinesAnimalsParticle SizeMaleDrug LiberationTissue DistributionRatsBiological AvailabilityRats, Sprague-DawleyDrug StabilitySolubility

Stichwörter der Autor:innen

aerosol inhalationaloperinenanostructured lipid carrierpharmacokinetics

Substanzen

Drug CarriersLipidsPiperidines

Autor:innen und Institutionen

  • School of Pharmacy, Ningxia Medical University, Yinchuan, 750004, People's Republic of China.
  • General Hospital of Ningxia Medical University, Yinchuan, 750004, People's Republic of China.
  • NHC Key Laboratory of Metabolic Cardiovascular Diseases Research, Ningxia Medical University, Yinchuan, 750004, People's Republic of China.
  • Ningxia Characteristic Traditional Chinese Medicine Modernization Engineering Technology Research Center, Ningxia Medical University, Yinchuan, 750004, People's Republic of China.

Zitieren

APA

Liu, H., Liu, S., Ma, P., Ma, L., Liu, Y., Zhao, F., & Zhou, R. (2025). Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s489133

Vancouver

Liu H, Liu S, Ma P, Ma L, Liu Y, Zhao F, et al. Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension. International Journal of Nanomedicine. 2025. doi:10.2147/ijn.s489133

BibTeX
@article{Liu2025,
  author = {Liu, Hui and Liu, Siyun and Ma, Pengsheng and Ma, Long and Liu, Yuxin and Zhao, Fang and Zhou, Ru},
  title = {Development and Evaluation of Aloperine-Loaded Nanostructured Lipid Carriers for the Treatment of Pulmonary Arterial Hypertension},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  doi = {10.2147/ijn.s489133}
}
Kostenlos starten →